Genetic Basis of Odor Discrimination
1 other identifier
observational
512
1 country
1
Brief Summary
Prior to the main study we will perform a pilot study on 60 subjects. The purpose of the pilot study is to identify the range of odor concentrations that will be used in the main study and to optimize the tasks performed in the main study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2009
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2009
CompletedFirst Submitted
Initial submission to the registry
December 23, 2009
CompletedFirst Posted
Study publicly available on registry
December 25, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2012
CompletedSeptember 6, 2012
September 1, 2012
2.8 years
December 23, 2009
September 5, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of correct responses when discriminating between (-)-carvone and (+)-carvone, isovaleric acid and isobutyric acid, androstenone and androstadienone DNA sequence of ORs sensitive to these odors
3 years
Secondary Outcomes (1)
concentration at which odors need to be added to allow for discrimination; thresholds to all six odors; verbal descriptors assigned to all six odors
3 years
Eligibility Criteria
Healthy volunteers
You may qualify if:
- Age 18-50
- Current non-smokers
You may not qualify if:
- Current smokers
- Allergy to fragrances or smells of any kind
- Active head cold, upper respiratory infection, or seasonal nasal allergies
- History of nasal health problems, including endoscopic nasal surgery for sinus conditions or polyp removal.
- Pre-existing medical condition that has caused anosmia or near total loss of the sense of smell, such as: head injury, cancer therapy, radiation to head and neck, or alcoholism
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Rockefeller University
New York, New York, 10065, United States
Biospecimen
Blood sample taken
Study Officials
- PRINCIPAL INVESTIGATOR
Leslie Vosshall, PhD
The Rockefeller University
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 23, 2009
First Posted
December 25, 2009
Study Start
November 1, 2009
Primary Completion
August 1, 2012
Study Completion
August 1, 2012
Last Updated
September 6, 2012
Record last verified: 2012-09